Know Cancer

or
forgot password

A Prospective and Observational Cohort Study to Evaluate the Treatment Model and Medical Economics of Advanced Gastric Cancer Chemotherapy in Clinical Practice in China


N/A
18 Years
85 Years
Open (Enrolling)
Both
Advanced Gastric Cancer

Thank you

Trial Information

A Prospective and Observational Cohort Study to Evaluate the Treatment Model and Medical Economics of Advanced Gastric Cancer Chemotherapy in Clinical Practice in China


Inclusion Criteria:



1. The patient has histologically confirmed locally-advanced or recurrent and/or
metastatic gastric or esophagogastric junction adenocarcinoma, has missed the
opportunity of surgical excision, making curative therapy impossible.

2. The informed consent form is signed.

3. A specimen of tumor tissue (puncture biopsy or surgical specimen) is available.

4. ECOG performance status is 0, 1 or 2.

5. The patient's general conditions and functions of important organs allow generalized
chemotherapy according to the investigator's judgment

6. The patient is aged≥18

Exclusion Criteria:

1. The patient is known to be allergic to any study drug.

2. The patient is recruited in other clinical study or is planned to participate into
other clinical study.

3. The patient has previously accepted chemotherapy against advanced or metastatic
diseases (the patient may be recruited if the previous adjuvant therapy/neoadjuvant
therapy was completed more than 6 months before inclusion).

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

chemotherapy regimen

Outcome Description:

To evaluate the treatment model (singel or doublet or triplet chemotherapy)of patients with advanced gastric cancer in China

Outcome Time Frame:

2 months

Safety Issue:

No

Authority:

China: Food and Drug Administration

Study ID:

CGOG1002

NCT ID:

NCT01472250

Start Date:

November 2011

Completion Date:

February 2014

Related Keywords:

  • Advanced Gastric Cancer
  • Advanced Gastric Cancer
  • chemotherapy
  • quality of life
  • treatment expense
  • patients accepted first-line chemotherapy
  • Stomach Neoplasms

Name

Location